Citi analyst Laura Sutcliffe maintained a Hold rating on Cochlear today and set a price target of A$140.00.
According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.3% and a 50.29% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh.
In a report released on September 1, Morgan Stanley also maintained a Hold rating on the stock with a A$133.00 price target.
The company has a one-year high of A$303.74 and a one-year low of A$88.74. Currently, Cochlear has an average volume of 620.1K.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CHEOF in relation to earlier this year.
